The efficacy and safety of High-Frequency Deep Sclerotomy in treatment of chronic open-angle glaucoma patients.

High Frequency Deep Sclerotomy; efficacy and safety

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR201910823824561

Enrollment

Registered

2019-10-11

Start date

2016-07-02

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

Surgical treatment of open angle glaucoma HFDS

usual hypotensive medical treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: chronic open angle glaucoma resistant to medical treatment progression of field uncontrolled intraocular pressure

Exclusion criteria

Exclusion criteria: Previous glaucoma surgery Neovascular glaucoma Congenital glaucoma Uveitic glaucoma Traumatic glaucoma

Design outcomes

Primary

Measure	Time frame
Target intraocular pressure less than 21 mmHg in chronic open angle glaucoma patients. Prevent progression of field changes.	—

Secondary

Measure	Time frame
Protection of corneal endothelium after procedure by specular microscopy measuring mean central Endothelial cell count and coefficient of variation	—

Countries

Egypt

Contacts

Public ContactTarek El Beltagi

Research Institute of Ophthalmology

tarekelbeltagi@gmail.com+201002229645

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026